Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Bhavnani

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2000
Benchmarking in health-system pharmacy: current research and practical applicationsS M Bhavnani
The Annals of Pharmacotherapy|January 1, 1995
Monitoring of intravenous quinidine infusion in the treatment of Plasmodium falciparum malariaS M Bhavnani, S L Preston
International Clinical Psychopharmacology|March 1, 1996
Antipsychotic agents: a survey of the prevalence, severity and burden of side effectsS M Bhavnani, G M Levin
Current Opinion in Microbiology|October 26, 2000
New agents for Gram-positive bacteriaS M Bhavnani, C H Ballow
Antimicrobial Agents and Chemotherapy|April 24, 2003
Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: report from the ARREST programP G Ambrose, S M Bhavnani, R N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2009
Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditisS M Bhavnani, A Prakhya, J P Hammel, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trialsC M Rubino, S M Bhavnani, G Moeck, et al.
Pulmonary Pharmacology & Therapeutics|March 31, 2009
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adultsC M Rubino, S M Bhavnani, P G Ambrose, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2000
Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureusP A Moise, A Forrest, S M Bhavnani, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principlesH S Sader, S M Bhavnani, P G Ambrose, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2000
Benchmarking in health-system pharmacy: current research and practical applicationsS M Bhavnani
The Annals of Pharmacotherapy|January 1, 1995
Monitoring of intravenous quinidine infusion in the treatment of Plasmodium falciparum malariaS M Bhavnani, S L Preston
International Clinical Psychopharmacology|March 1, 1996
Antipsychotic agents: a survey of the prevalence, severity and burden of side effectsS M Bhavnani, G M Levin
Current Opinion in Microbiology|October 26, 2000
New agents for Gram-positive bacteriaS M Bhavnani, C H Ballow
Antimicrobial Agents and Chemotherapy|April 24, 2003
Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: report from the ARREST programP G Ambrose, S M Bhavnani, R N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2009
Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditisS M Bhavnani, A Prakhya, J P Hammel, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trialsC M Rubino, S M Bhavnani, G Moeck, et al.
Pulmonary Pharmacology & Therapeutics|March 31, 2009
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adultsC M Rubino, S M Bhavnani, P G Ambrose, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2000
Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureusP A Moise, A Forrest, S M Bhavnani, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principlesH S Sader, S M Bhavnani, P G Ambrose, et al.
Pageof 3